Table 2.
Expression rates (%) and transient peak currents (Imax) of wild type and specifically mutated Vssc1 co-expressed with Vsscβ in Xenopus oocytes
| AA residuea |
Nb | Vssc1 variant | % Expressionc | Imax ± SD (n)d | ||
|---|---|---|---|---|---|---|
| 827 | 929 | 932 | ||||
| M | T | L | 84 | Vssc1WT | 53.57 | 1.51 ± 0.85 (13) |
| I | T | L | 46 | Vssc1MI | 56.52 | 1.46 ± 1.37 (16) |
| M | I | L | 58 | Vssc1TI | 27.59e | 0.59 ± 0.17 (10)f |
| M | T | F | 52 | Vssc1LF | 32.73e | 2.32 ± 1.92 (11) |
| I | I | L | 36 | Vssc1MITI | 38.89 | 2.33 ± 1.35 (13) |
| I | T | F | 50 | Vssc1MILF | 58.00 | 1.46 ± 0.98 (15) |
| M | I | F | 50 | Vssc1TILF | 26.00e | 0.62 ± 0.16 (7)f |
| I | I | F | 98 | Vssc1MITILF | 47.96 | 0.84 ± 0.43 (10) |
Vssc1 variants are identified by the amino acid residues at positions 827, 929 and 932. The MTL (M827/T929/L932) variant is wildtype Vssc1 (Vssc1WT).
N, total number of oocytes co-injected with Vssc1 and Vsscβ cRNAs.
% Expression = (Oocytes producing TTX-sensitive sodium currents/total oocytes co-injected with the same amount of Vssc1 and Vsscβ cRNAs) × 100.
Number of eggs used to measure transient peak current.
Indicates percent expression of the specifically mutated Vssc1/Vsscβ variant is significantly less than that of Vssc1WT/Vsscβ (t-test, P < 0.05).
Amplitude of transient peak current significantly reduced compared to that of Vssc1WT/Vsscβ (t-test, P < 0.05).